Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2026-03-30 Capital/Financing Update
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Zawarcie umowy o dofinansowanie w ramach programu FENG / Conclusion of a Co-Funding Agreement under the FENG Program - Content (PL)
Capital/Financing Update Classification · 82% confidence The document is a corporate current report informing that the company entered into a co-financing agreement with a government body for an R&D project. This is not an annual or interim report, nor a board change or earnings release. It is an update on financing activities (grant funding). Therefore it fits the Capital/Financing Update category.
2026-03-30 Polish
Zawarcie umowy kredytu hipotecznego / Conclusion of a Mortgage Loan Agreement - Content (EN)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement regarding the conclusion of a credit/loan agreement between Selvita S.A. and Bank Pekao. It details the loan amount, purpose (construction of a Research and Development Centre), interest rates, repayment schedule, and collateral. This falls under the category of company financing and capital structure updates.
2026-03-17 English
Zawarcie umowy kredytu hipotecznego / Conclusion of a Mortgage Loan Agreement - Content (PL)
Capital/Financing Update Classification · 100% confidence The document is a formal announcement by Selvita S.A. regarding the signing of a credit agreement with Bank Polska Kasa Opieki S.A. It details the loan amount, purpose (construction of a research center), interest rates, repayment schedule, and security measures. This type of disclosure regarding corporate financing and debt arrangements falls under the 'Capital/Financing Update' category.
2026-03-17 Polish
Zawarcie umowy kredytu obrotowego / Conclusion of a Working Capital Facility Agreement - Content (PL)
Capital/Financing Update Classification · 100% confidence The document is an official announcement regarding the signing of a new revolving credit facility agreement between Selvita S.A. and Bank Pekao. It details the loan amount, interest rate structure, maturity date, and the specific collateral/security arrangements (mortgages, promissory notes, guarantees). This falls squarely under the definition of a Capital/Financing Update, as it describes a specific financing activity and changes to the company's capital structure/debt obligations.
2026-03-17 Polish
Zawarcie umowy o dofinansowanie w ramach programu FENG / Conclusion of a Co-Funding Agreement under the FENG Program - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (663 characters) from Selvita S.A. regarding the signing of a funding agreement for a specific project with the National Centre for Research and Development. It does not constitute a full financial report, audit, or proxy statement. As it is a specific corporate announcement regarding a financing/grant agreement that does not fit into the other specific categories like M&A or share issuance, it is best classified as a general regulatory filing.
2026-03-16 Polish
Zawarcie umowy o dofinansowanie w ramach programu FENG / Conclusion of a Co-Funding Agreement under the FENG Program - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is a short announcement (655 characters) regarding the signing of a funding agreement between Selvita S.A. and the National Centre for Research and Development. It does not contain full financial statements or detailed project reports, but rather serves as a formal notification of a corporate event (securing funding). Since it does not fit into specific categories like M&A or share issues, and is a standard regulatory disclosure of a business development, it falls under the general regulatory filing category.
2026-03-02 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.